Education
About Us
Working with TipRanks
Follow Us
Fractyl Health, Inc. (GUTS)
NASDAQ:GUTS
Earnings Data
Report Date
Apr 06, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.48Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Fractyl Health, Inc. is experiencing significant clinical and financial progress, particularly with the Revita procedure's promising results in sustaining weight loss post-GLP-1 therapy and robust financial positioning. However, the increased net loss and weight regain in the sham group highlight some challenges.Company Guidance
Revita Procedure Success
First randomized double-blind sham-controlled data showing a single Revita procedure can sustain weight loss after GLP-1 drug discontinuation, with Revita-treated patients losing an additional 2.5% total body weight.
Strong Financial Position
Fractyl Health has $77.7 million in cash and cash equivalents, with a cash runway extending into early 2027 due to recent underwritten offerings totaling $83 million.
Rapid Enrollment and Randomization
The REMAIN one pivotal cohort was completed in Q2, with over 60% of participants randomized by October 31. Randomization is ahead of schedule, expected to complete early in 2026.
Promising Results from German Registry Study
Patients maintained an average of 9% total body weight loss and a 1.7% reduction in HbA1c over two years, with durable outcomes strengthening confidence in Revita's long-term efficacy.
Rejuva-002 Preclinical Success
Rejuva-002 candidate for obesity showed nearly 30% body weight loss after a single dose in a preclinical model with no observed adverse effects.
GUTS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GUTS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $1.13 | $1.12 | -0.88% |
Aug 12, 2025 | $0.98 | $1.01 | +3.06% |
May 13, 2025 | $1.77 | $1.54 | -12.99% |
Mar 03, 2025 | $1.56 | $1.50 | -3.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fractyl Health, Inc. (GUTS) report earnings?
Fractyl Health, Inc. (GUTS) is schdueled to report earning on Apr 06, 2026, Before Open (Confirmed).
What is Fractyl Health, Inc. (GUTS) earnings time?
Fractyl Health, Inc. (GUTS) earnings time is at Apr 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GUTS EPS forecast?
GUTS EPS forecast for the fiscal quarter 2025 (Q4) is -0.18.